domo.health Launches Generative AI to Transform Homecare by Reducing Administrative Burdens and Enhancing Collaboration
plus
Actualités sur Medizin, Gesundheit
Schweizerischer Nationalfonds / Fonds national suisse
Animal experiments: SNSF warns of consequences of a ban
Bern (ots) - The popular initiative in favour of banning animal experiments would significantly weaken Switzerland as a centre of research. Furthermore, animal testing could be relocated to countries with much less stringent welfare rules. The popular initiative "Ja zur tierversuchsfreien Zukunft" (Yes to a future without animal testing) aims to ban animal experiments in Switzerland. This would massively restrict human ...
plusGrünenthal and Averitas Pharma announce completion of recruitment for Phase III clinical trial with QUTENZA® in post-surgical neuropathic pain
Aachen, Germany/Morristown, N.J. (ots) - - The Phase III trial AV001 aims to evaluate QUTENZA® in post-surgical neuropathic pain (PSNP), a debilitating complication of surgery occurring after approximately 10 percent of all surgical procedures[1], thus affecting more than 3 million people with surgical procedures ...
plusPulsenmore Expands Partnership with Clalit Health Services to Deliver 25,000 Home Ultrasound Devices for Remote Prenatal Care
Ramat Gan, Israel (ots/PRNewswire) - Pulsenmore (TASE: PULS), a pioneering provider of home-based ultrasound technology, has announced the renewal and expansion of its strategic partnership with Clalit Health Services, Israel's largest HMO. Over the next five years, Pulsenmore will supply 25,000 units of its ...
plusFirst participants enrolled in first-in-human Phase I clinical trial with nociceptin (NOP) receptor agonist
Aachen, Germany (ots) - Today, Grünenthal announced that the first participants have been enrolled in a first-in-human Phase I clinical trial for a nociceptin (NOP) receptor agonist. The trial will include 90 healthy volunteers and aims to demonstrate a favourable safety and tolerability profile and to confirm the ...
plusEpitomee Medical to Present the Epitomee Breakthrough Oral Delivery Platform at PODD 2024 Conference
Caesarea, Israel (ots/PRNewswire) - Epitomee Medical Ltd. (TASE: EPIT) announces today that the company leadership intends to present Epitomee's Oral Delivery of Biologics Platform at the 14th Annual PODD Conference - Partnership Opportunities in Drug Delivery, taking place in Boston, MA, October 28-29, 2024. ...
plusRockefeller Foundation Joins G20 Global Alliance Against Hunger and Poverty to Advance Climate-Resilient School Meals
Rome (ots/PRNewswire) - The Rockefeller Foundation became the first philanthropy to join the Global Alliance Against Hunger and Poverty (Global Alliance) at an event today with its President Rajiv Shah, the Brazilian Ambassador to the Rome-based Agencies, Carla Barroso Carneiro, and The Food and Agriculture ...
plusNorgine Announces Appointment of New CEO Janneke van der Kamp
London (ots/PRNewswire) - Norgine (the "Company"), a leading European specialty pharmaceutical company, has today announced the appointment of Janneke van der Kamp as its new Chief Executive Officer (CEO), effective from 1 January 2025. Current CEO, Chris Bath, has stepped down from his role effective immediately. This change in leadership will support and enhance the Company's mission of bringing transformative medicines ...
plusSchweizerischer Nationalfonds / Fonds national suisse
Full-time employees face higher risk of cancer
Bern (ots) - Working at 100% is linked to a higher incidence of the disease, according to an SNSF-funded study. Self-employed men and women who stay at home fared best, but the explanation is not as straightforward as it might seem. Some of the risk factors for cancer are well known - smoking, alcohol, a sedentary lifestyle - while others are a bit harder to explain. For example, work. As part of the completed, ...
plusGrünenthal appoints Dr. Jan Adams as Chief Commercial Officer
Aachen, Germany (ots) - Grünenthal announced today that Jan Adams, M.D., currently Chief Scientific Officer (CSO) and member of the Corporate Executive Board, will assume the role of Chief Commercial Officer (CCO) effective 1 October 2024. Prior to his role as CSO, he was Head of Strategy and Portfolio at Grünenthal. Jan Adams has over two decades of experience in the pharmaceutical and healthcare industry. Since ...
plusMSD in Strategic collaboration with Briya for Innovative RWE data analysis projects
Tel Aviv, Israel (ots/PRNewswire) - MSD, a leading multinational pharmaceutical company successfully completes a first-of-its-kind strategic collaboration with Briya, a medical data retrieval network. This groundbreaking partnership enabled innovative data analysis projects on three critical disease areas MSD plays a part in. Leveraging Briya's advanced data platform, ...
plusEpitomee Medical Announces FDA Clearance of its Capsule, Weight Management Device
Caesarea, Israel (ots/PRNewswire) - Epitomee's Ingestible Capsule, Offers a Safe and Effective Prescription Solution for Adults with BMI of 25-40 looking for Alternative Drug Free Solutions for Their Weight Management Needs alongside diet and exercise. Epitomee Medical Ltd. (TASE: EPIT), announced that the United States Food and Drug Administration (FDA) has officially ...
plusScantox Group acquires Gentronix, a world leader in genetic toxicology
Ejby, Denmark (ots/PRNewswire) - Today Scantox, together with its majority owner Impilo, finalized the acquisition of Gentronix Ltd, a UK based GLP compliant genetic toxicology Contract Research Organization ("CRO"). Gentronix, now integrated into Scantox Group, is well recognized for its high-quality genetic toxicology services and strong scientific engagement, with ...
plusNew insights highlight unmet needs for people living with Lennox-Gastaut syndrome and significant burden of the disease
Brussels (ots/PRNewswire) - - New data presented at the 15th European Epilepsy Congress highlight lengthy delays in Lennox-Gastaut syndrome (LGS) diagnosis in Europe and significant disease burden from both seizure and non-seizure impairments[1] - LGS is a severe childhood-onset developmental and epileptic ...
plusINSIGHTEC; Charles River Laboratories International, Inc.
Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience
Wilmington, Mass., Miami and Haifa, Israel (ots/PRNewswire) - Collaboration stands to advance novel therapeutic applications across multiple neurologic conditions Charles River Laboratories International, Inc. (NYSE: CRL) and Insightec, a global healthcare company dedicated to using focused ultrasound to transform ...
plusGabriel Millan joins Mars as Chief Financial Officer for Petcare business
Brussels (ots/PRNewswire) - - Mars announces Gabriel Millan as new CFO for Petcare, Millan will join the Mars Petcare Leadership Team and global Finance Leadership Team - Recognized finance leader with over 25 years' experience in Fortune-500/FTSE-100 companies across consumer goods and life sciences, to join Mars from GSK Today, Mars named Gabriel Millan as Chief ...
plusAcousia Therapeutics to present its clinical Phase 2 PROHEAR study on hearing loss treatment candidate ACOU085 at upcoming conferences
Tübingen, Germany (ots) - Acousia Therapeutics GmbH, a Tübingen-based clinical stage biotech company focused on the enhancement and preservation of natural hearing, will be presenting the ACOU085 Phase 2 PROHEAR clinical study at the HansonWade 4th Inner Ear Disorders Therapeutics Summit in Boston (MA) from August ...
plusGrünenthal acquires US-company Valinor Pharma and becomes global owner of Movantik®
Aachen, Germany (ots) - - Grünenthal acquires the pharmaceutical company Valinor Pharma, further strengthening Grünenthal’s footprint in the United States. - With the acquisition, Grünenthal becomes the global owner of Movantik® / Moventig® (naloxegol). - Since 2017, Grünenthal has invested more than €2 billion in successful M&A transactions, significantly ...
plus- 2
Press Release Kunstmuseum St.Gallen | RM: Anus Horribilis
Un documentplus Grünenthal announces significant investments in its Latin America production sites, further securing reliable medicine supply for patients
Aachen, Germany (ots) - - Investment of more than €80 million to modernise Latin American production sites. - In Santiago de Chile, a 3,500-square-metre solids plant has been completely refurbished, creating a world-class manufacturing facility with a production capacity of 1.8 billion tablets annually. - In ...
plusSchweizerischer Nationalfonds / Fonds national suisse
The tumour hacker
plusMedasense Announces a Strategic Agreement With Global Medical Company, Nihon Kohden Corporation
Ramat Gan, Israel (ots/PRNewswire) - Medasense, a global leader in pain monitoring solutions, is proud to announce a strategic partnership with Nihon Kohden for the exclusive distribution of its revolutionary pain monitoring device in Japan. This partnership is intended to transform pain management practices across Japanese healthcare facilities, offering a significant ...
plusBerlinger Group adopts new strategic alignment
Ganterschwil, SG / Beverly, MA, USA (ots) - +++ Cold chain monitoring systems business to be acquired by US-based Sensitech Inc. +++ Anti-doping product business to remain in family ownership +++ The Berlinger Group, which is internationally renowned for both its anti-doping products and its high-tech cold chain monitoring systems, is adopting a new strategic alignment. Berlinger & Co. AG, the group's cold chain ...
plusRenowned Public Health Expert Prof. Siegal Sadetzki Joins Briya
Tel Aviv, Israel (ots/PRNewswire) - Briya, a leading medical data retrieval network, proudly announces the appointment of Prof. Siegal Sadetzki as Chief Epidemiology Officer. With over three decades of experience in public health and epidemiology, Prof. Sadetzki brings a wealth of expertise to Briya's mission of making medical data accessible for research at scale and assisting hospitals in optimizing their data ...
plusATTEND FDI WORLD DENTAL FEDERATION'S VIRTUAL SUMMIT SHOWCASING SUSTAINABLE PRACTICES IN DENTISTRY TO REDUCE THE PROFESSION'S ENVIRONMENTAL IMPACT
plusSchweizerischer Nationalfonds / Fonds national suisse
Back pain sufferers need patience more than anything else
Bern (ots) - Temporary complaint or chronic affliction: a research team funded by the SNSF has identified typical trajectories for back pain. Psychosocial factors play a smaller role than expected. Back pain is a widespread condition: at least once in their lives, almost 85% of people will experience pain in the area of the lumbar spine, in other words between the bottom rib and the tailbone. Treating this correctly is ...
plusSoterios Pharma Announces Positive Topline Results from Phase II Study of STS-01 in the Treatment of Mild / Moderate Alopecia Areata
London (ots/PRNewswire) - - Once-daily topical treatment of mild / moderate alopecia areata (AA) with 1% STS-01 met the primary efficacy endpoint of >30% Severity of Alopecia Tool (SALT) score improvement compared to patients receiving placebo ...
plusLifespin GmbH and Acıbadem Forge a Groundbreaking Metabolomics Partnership to Advance Personalized Medicine
Istanbul and Regensburg, Germany (ots/PRNewswire) - lifespin GmbH, a pioneer in health status detection software, has teamed up with Acıbadem University (ACU) and Acıbadem Healthcare Group (AHG) to launch a comprehensive precision medicine initiative, a significant stride towards revolutionizing personalized ...
plusSchweizerischer Nationalfonds / Fonds national suisse
NRP "Welfare and Coercion" identifies areas for improvement in Swiss social policy
plusSchweizerischer Nationalfonds / Fonds national suisse
Compassion doesn't help all couples
Bern (ots) - More compassion = a better relationship. This is an obvious rule of thumb for couples. But it doesn't apply to everyone, as a study shows. Some people prefer to do without it. Whether irrevocably estranged or merely bored with the daily routine: "Couples counselling can improve communication and the quality of the relationship. And it has a positive effect on mental health", says Andrew Gloster, Professor of ...
plus
12345678910Suivant